Amarin to Present at the Jefferies 2012 Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at the Jefferies 2012 Global Healthcare Conference
Amarin Announces FDA Acceptance for Filing of AMR101 NDA Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces FDA Acceptance for Filing of AMR101 NDA
Amarin Announces Dosing of First Patient in Cardiovascular Outcomes Study REDUCE-IT Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Dosing of First Patient in Cardiovascular Outcomes Study REDUCE-IT
Amarin Announces the Addition of Industry Veteran Patrick O'Sullivan to Board Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces the Addition of Industry Veteran Patrick O'Sullivan to Board
Amarin Announces Appointment of Joseph T. Kennedy as General Counsel and Issuance of Inducement Grant Under NASDAQ Rule 5635(c)(4) Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces Appointment of Joseph T. Kennedy as General Counsel and Issuance of Inducement Grant Under NASDAQ Rule 5635(c)(4)
Amarin Commences 2012 With Letter to Shareholders Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Commences 2012 With Letter to Shareholders
Amarin Corporation plc Announces Offering of $150 Million of Exchangeable Senior Notes Due 2032 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Corporation plc Announces Offering of $150 Million of Exchangeable Senior Notes Due 2032
Amarin Corporation plc Announces Pricing of $150 Million of Exchangeable Senior Notes Due 2032 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Corporation plc Announces Pricing of $150 Million of Exchangeable Senior Notes Due 2032
Amarin to Present at the Leerink Swann 2012 Global Healthcare Conference Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin to Present at the Leerink Swann 2012 Global Healthcare Conference
Amarin Announces FDA Advisory Committee Will Not Be Scheduled in Connection With New Drug Application for AMR101 Submitted by amarin on Fri, 12/08/2017 - 04:48 Home Read more about Amarin Announces FDA Advisory Committee Will Not Be Scheduled in Connection With New Drug Application for AMR101
